1. Home
  2. SST vs EVGN Comparison

SST vs EVGN Comparison

Compare SST & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo System1 Inc.

SST

System1 Inc.

HOLD

Current Price

$3.76

Market Cap

12.9M

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.51

Market Cap

11.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SST
EVGN
Founded
2013
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Diversified Commercial Services
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
11.1M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
SST
EVGN
Price
$3.76
$0.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.00
$3.50
AVG Volume (30 Days)
1.4M
157.4K
Earning Date
05-06-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$266,129,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$0.37
52 Week High
$9.30
$1.50

Technical Indicators

Market Signals
Indicator
SST
EVGN
Relative Strength Index (RSI) 64.50 39.99
Support Level $1.63 $0.45
Resistance Level $4.92 $0.86
Average True Range (ATR) 0.57 0.03
MACD 0.25 -0.01
Stochastic Oscillator 57.03 9.08

Price Performance

Historical Comparison
SST
EVGN

About SST System1 Inc.

System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: